After several years of evolutionary changes, the Center for Medicare and Medicaid Services (CMS) announced on January 26, 2015, a timeline of moving from volume to value in Medicare payments; i.e., from 30 percent of provider payments in 2016 to 50 percent by 2018.1Implementation of the Comprehensive Care Joint Replacement (CJR) initiative signals an intention to mandate, at least for targeted geographic areas, a value-oriented payment system across the entire continuum of care, from surgery and inpatient care, to post-acute care recovery and rehabilitation.
Average hip and knee implant costs represent 25 to 40 percent of DRG reimbursement for lower extremity hip and new replacement +/- complications. Given the high cost of implants, and the ability of supply chain personnel to analyze materials management, OR financial data, an opportunity exists to utilize their work-flow and process expertise to facilitate an analysis of provider variation across the entire continuum of care. This would require the integration of electronic medical record (EMR) data and the addition of clinical (nurse) expertise.
In this article, we discuss the CJR, the consistently wide variation in the total cost of care (inclusive of post-acute) for joint replacement within specified U.S. regions, and the critical role of analytics to facilitate efficiency and effectiveness, and by default, competitive advantage. Future success in a value-oriented payment environment requires participation in a CJR-like effort, whether mandatory or not.
READ THE FULL ARTICLE
Comprehensive Care Joint Replacement: A Strategic Mandate for Providers (pdf)
Medical Device Supply Chains: Disruption Is Permanent. Is the Industry Ready?
June 18, 2026
Medical device supply chains are under increasing pressure as global disruption becomes a constant rather than an exception. From geopolitical volatility to material scarcity and regulatory complexity, the sector now operates in an environment where even minor shocks can have far-reaching consequences. This article explores the structural vulnerabilities shaping today’s MedTech supply networks and highlights why traditional approaches are no longer sufficient. It outlines how leading organisations are rethinking resilience not just as risk mitigation, but as a source of competitive advantage in an increasingly unpredictable world. Download the full article to uncover the strategies that are helping companies respond faster, protect patient outcomes, and maintain operational continuity.
Episode 2: Don Antonucci, President and CEO, Providence Health Plan
June 16, 2026
In this episode, Don Antonucci, President and CEO of Providence Health Plan joins A&M Healthcare Industry Group's Craig Savage and Mike Epstein to share how health plans can maintain stability while delivering value to members.
Building AI from Within at Nebraska Medicine
May 28, 2026
What if the real advantage isn’t buying the latest solution, but building your own? Michael Hasselberg, Chief Transformation and Digital Officer at Nebraska Medicine joins A&M Healthcare Industry Group's Seth Ciabotti and Travis Sherman to share how Nebraska Medicine is building AI capabilities internally—from assembling in-house data science and engineering teams to deploying enterprise tools that address real operational pain points.
Medical Management Is Broken Getting AI Right Will Decide Which Plans Survive
May 7, 2026
AI is reshaping medical management from a cost center into a strategic engine for health plans. In this paper, Managing Directors Bryan Komornik and Craig Savage outline where AI is delivering real value today and how plans can modernize clinical operations to improve cost, quality, and experience.
